Nintedanib is a medication, used to treat troublesome lung disease - idiopathic pulmonary fibrosis (IPF).

It is commonly known as lung cancer. In this disease, the lungs develop scars and stiffen, making breathing difficult. The medicine Nintedanib 150 mg is known to help in slowing down the worsening of IPF disease.

Being a disease that gets worse over time, it is wise to start treatment at an initial stage and continue with the treatment. So, it is important to get a treatment that does not disturb your bank balance, while ensuring that patients get the treatment benefits in the long run.

Nintedanib 150 mg tablet is approved by the Indian drug regulator for the treatment of idiopathic pulmonary fibrosis (IPF) and is the prescribed treatment of this disease.

Simply put, Nintedanib is the salt/ingredient (generic name) of the medicine.

In India, some of the companies are manufacturing generic versions of Nintedanib brand such as Glenmark Pharmaceuticals, Cipla Ltd.

Nintedanib 150 mg tablet uses

Nintedanib medication is used for -

• Nintedanib is consumed to treat IPF (idiopathic pulmonary fibrosis), which scars the lungs with an unknown cause.
• It is also used to treat chronic fibrosing ILD (interstitial lung disease), in which scarring of the lungs increases.
• The medicine is also helpful in slowing the rate of decline in lung function in patients with SSc-ILD (systemic sclerosis-associated interstitial lung disease), also known as scleroderma-associated ILD. This is a disease in which scarring of the lungs is often fatal.
• Nintedanib 150 mg belongs to a class of medications called kinase inhibitors. It works by blocking the action of enzymes that are involved in causing fibrosis.
• Nintedanib is usually taken every 12 hours (twice a day), at around the same times every day.
• The doctor may decrease the patient’s dose or stop treatment completely if certain severe side effects are experienced. It is thus important to clearly convey to the doctor how a patient is feeling during the treatment.

Nintedanib 150 mg (Generic) brands in India

The brands that have launched Nintedanib 100 and 150 mg capsules in India include -

Nindanib (Nintedanib) Mfg. Glenmark Pharma – The company is claimed to be the first one to launch the branded generic version of Nintedanib as Nindanib in India. It has made the medicine available at an affordable cost in India, facilitating the treatment of pulmonary fibrosis. This has been helping patients get a treatment option at pocket-friendly rates. Doctors are also equipped with a convenient way to reach more patients for treatment and cure.

Nintena (Nintedanib) Mfg. Sun Pharmaceutical: - Nintedanib is available as Nintena under this brand name.

Nintib (Nintedanib) Mfg. Cipla Ltd – The renowned brand has launched the generic Nintedanib. It is now marketed under the brand name Nintib.

Lupin – This leading pharmaceutical company also launched Nintedanib - an anti-cancerous medicine as Idofnib.

Zydus Cadila – The medicine is introduced as Nindev by this famous pharmaceutical brand.

Boehringer Ingelheim – One of the top-selling drugs manufactured by this highly reputed brand in India is dedicated to oncology. It has made Nintedanib available in India as

How much does Nintedanib 150 mg cost in India?

The cost of Nintedanib 150 mg (generic brands) in India is very low as compare to the international brands.

Many people all around the world prefer to buy this medicine directly from India because of its low cost and the quality is the same as the brand.

Please contact delightaid health.

Where can you buy Nintedanib online?

You can easily buy Nintedanib online as it is widely available in several medicine stores in India, However, before buy please check supplier credibility.

At Delightaid Health, we can help you to get this medicine at the lowest possible cost.
Please contact us via Email, WhatsApp or simply filling the query form in our website bottom section or contact us page.

What are the side effects of Nintedanib

Common side effects of Nintedanib include:

• Diarrhea
• Nausea
• Stomach or abdominal pain
• Vomiting
• Liver problems and liver enzyme elevation
• Decreased appetite
• Headache
• Weight loss
• High blood pressure (hypertension)

In a nutshell, Nintedanib has entered the medicine market of India as a boon to patients struggling with lung cancer and related severities. The medicine effectively blocks the abnormal protein that helps cancer cells multiply.

Thereby, checking their fatal spread or at least slowing it down, so that the patient’s life span is increased while being relieved. This breakthrough in the pharmaceuticals’ world is on its way to bring forth more advancements and easing the severities of IPF.